155,512 Shares of Kenvue Inc. $KVUE Acquired by Leo Wealth LLC

Key Points

• Leo Wealth LLC acquired 155,512 Kenvue shares during the third quarter, valued at approximately $2.75 million. Institutional investors collectively own 97.64% of Kenvue’s stock.
• Analysts remain cautious, with all 10 covering the company rating it “Hold.” Kenvue has a consensus price target of $18.50, below its reported trading price of $19.48.
• Kenvue’s latest quarterly results slightly missed expectations, with $0.31 EPS and $3.96 billion in revenue, while revenue increased 3% year over year. The company pays a quarterly dividend of $0.21 per share, representing a 4.3% yield.

Leo Wealth LLC acquired a new stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 155,512 shares of the company's stock, valued at approximately $2,746,000.

Other institutional investors have also recently made changes to their positions in the company. Johnson Financial Group Inc. bought a new stake in Kenvue in the 2nd quarter worth approximately $26,000. CoreCap Advisors LLC raised its holdings in shares of Kenvue by 64.9% during the 2nd quarter. CoreCap Advisors LLC now owns 1,502 shares of the company's stock worth $29,000 after acquiring an additional 591 shares in the last quarter. GK Wealth Management LLC purchased a new stake in shares of Kenvue during the 3rd quarter worth approximately $27,000. Bell Investment Advisors Inc purchased a new stake in shares of Kenvue during the 2nd quarter worth approximately $35,000. Finally, Keating Financial Advisory Services Inc. purchased a new stake in shares of Kenvue during the 2nd quarter worth approximately $38,000. Hedge funds and other institutional investors own 97.64% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Weiss Ratings reissued a "hold (c)" rating on shares of Kenvue in a report on Friday, September 11th. Zacks Research cut shares of Kenvue from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 7th. UBS Group decreased their price target on shares of Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a research note on Tuesday, August 11th. Wall Street Zen lowered shares of Kenvue from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. Finally, Barclays increased their price objective on shares of Kenvue from $18.00 to $19.00 and gave the company an "equal weight" rating in a research report on Tuesday, July 21st. Ten equities research analysts have rated the stock with a Hold rating. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $18.50.

Kenvue Trading Down 0.4%

KVUE opened at $19.48 on Tuesday. The firm has a market cap of $37.43 billion, a P/E ratio of 16.58, a P/E/G ratio of 1.79 and a beta of 0.48. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $20.13. The company has a current ratio of 1.01, a quick ratio of 0.71 and a debt-to-equity ratio of 0.67. The stock has a 50-day moving average of $18.36 and a 200 day moving average of $18.12.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.31 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.32 by ($0.01). The company had revenue of $3.96 billion for the quarter, compared to analysts' expectations of $3.97 billion. Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The company's revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter last year, the company earned $0.29 earnings per share. As a group, research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 2nd. Stockholders of record on Monday, September 21st were given a dividend of $0.21 per share. The ex-dividend date of this dividend was Monday, September 21st. This represents a $0.84 annualized dividend and a dividend yield of 4.3%. Kenvue's payout ratio is currently 96.55%.

About Kenvue

Kenvue Inc is a consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, and essential health products, serving consumers through retail, e-commerce and other distribution channels.

The company's brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; and Listerine, Johnson's and OGX in oral care, baby care and hair care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.